The Malaysian Reserve

Lilly’s baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial

This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often ...
Scientific Research Publishing

Building Bridges, Not Barriers: A Brief Study of Developing Mathematical Resilience in FE GCSE Mathematics Resit Students ()

Rashid, M. and Johnston-Wilder, S. (2025) Building Bridges, Not Barriers: A Brief Study of Developing Mathematical Resilience in FE GCSE Mathematics Resit Students. Creative Education, 16, 1637-1650.
TechAnnouncer

Google Quantum Computer: Solving Problems in 10,000 Years or Less?

So, Google’s quantum computer is making waves again. You might have heard some buzz about it solving problems that would take ...

How can brands stand out in the attention economy?

Are you listening closely? Good, then let’s begin. With the attention economy a hot topic, The Drum polled its members for ...
The Malaysian Reserve

Lilly’s EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis

New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the ...